Healthcare & Life Sciences
Human Immunology Biosciences
United Kingdom
series-a
series-a
Stage
1
Investors
About
Human Immunology Biosciences is a clinical-stage biotechnology company developing targeted therapies for severe immune-mediated diseases, focusing on felzartamab, a human monoclonal antibody against CD38.
Explore Human Immunology Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.